Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

A Study to Evaluate Long Term Safety and Efficacy of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis

ClinicalTrials.gov ID: NCT04594707

Public ClinicalTrials.gov record NCT04594707. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 12:33 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Open-label Extension Study to Evaluate Long-term Safety and Efficacy of PRM-151 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will evaulate the long-term safety, efficacy and pharmacokinetics (PK) of recombinant human pentraxin-2 (rhPTX-2; PRM-151) zinpentraxin alfa, administered by intravenous (IV) infusion to participants with idiopathic pulmonary fibrosis (IPF).

Study identification

NCT ID
NCT04594707
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
117 participants

Conditions and interventions

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 30, 2021 (Actual)
Primary completion
Feb 10, 2023 (Actual)
Completion
Feb 10, 2023 (Actual)
Last update posted
May 16, 2024

2021 – 2023

United States locations

U.S. sites
40
U.S. states
23
U.S. cities
40
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294 —
University of California Davis Sacramento California 95817 —
Inst. of Healthcare Assessment, Inc. San Diego California 92120 —
UCSF Medical Center San Francisco California 94143-0748 —
National Jewish Health Medical Center Denver Colorado 80045-2541 —
Yale New Haven Hospital New Haven Connecticut 06510 —
Georgetown University Medical Center Washington D.C. District of Columbia 20007 —
Meris Clinical Research Brandon Florida 33511-5719 —
Florida Lung, Asthma and Sleep Specialists (FLASS) - Celebration Celebration Florida 34747-1818 —
Advanced Pulmonary & Sleep Research Institute of Florida Daytona Beach Florida 32117 —
University of Florida Health Pulmonology - Jacksonville Jacksonville Florida 32209 —
Advanced Pulmonary Research Institute Loxahatchee Groves Florida 33470-9216 —
Sarasota County Public Hospital Sarasota Florida 34239 —
Renstar Medical Research Wesley Chapel Florida 33544 —
Florida Pulmonary Research Institute, LLC Winter Park Florida 32789 —
NorthShore University HealthSystem Evanston Illinois 60201 —
University of Iowa Hospitals and Clinics; Investigational Drug Services Iowa City Iowa 52242 —
University of Kansas Medical Center Kansas City Kansas 66160 —
University of Louisville Health Sciences Center Louisville Kentucky 40202 —
Massachusetts General Hospital Boston Massachusetts 02114 —
University of Minnesota Medical Center Minneapolis Minnesota 29425-8911 —
Mayo Clinic Rochester Rochester Minnesota 55902 —
The Lung Research Center Chesterfield Missouri 63017-3625 —
Washington University St Louis Missouri 63128 —
University of Nebraska Medical Center Omaha Nebraska 68198-0600 —
Lenox Hill Hospital New York New York 10075 —
Pulmonix Research Greensboro North Carolina 27403-1127 —
PMG Research of Wilmington Wilmington North Carolina 28401 —
Oregon Health and Science University Portland Oregon 97239 —
Jefferson University Physicians (JUP) - Jefferson Pulmonary Philadelphia Pennsylvania 19107 —
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213 —
SleepMed of South Carolina Columbia South Carolina 29201-2953 —
Lowcountry Lung and Critical Care North Charleston South Carolina 29406 —
Spartanburg Medical Center Spartanburg South Carolina 29303 —
Vanderbilt University Medical Center Nashville Tennessee 37212 —
University of Texas Medical Branch at Galveston Galveston Texas 77555 —
Metroplex Pulmonology & Sleep Center McKinney Texas 75069 —
University Of Utah Hosp & Clin; Investigational Pharmacy Salt Lake City Utah 84132 —
Inova Fairfax Hospital Falls Church Virginia 22031 —
Virginia Commonwealth University Richmond Virginia 23219-1901 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 208 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04594707, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 16, 2024 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04594707 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →